IRLAB Therapeutics is taking steps in preparation for a Phase 3 clinical program of mesdopetam, an experimental medicine for…
Articles by Margarida Maia, PhD
Loneliness raises a person’s risk of developing Parkinson’s disease within 15 years, a long-term study of nearly half a…
Vincere Biosciences has been given $700,000 in seed funding by the National Institutes of Health (NIH) to advance…
Interfering with the circadian clock, or the body’s internal clock, may make dopaminergic neurons — the nerve cells that become…
Patients who are on long-term levodopa to treat Parkinson’s disease are more likely to experience self-reported freezing of…
While it appears that people with attention deficit hyperactivity disorder (ADHD) are more likely to develop Parkinson’s disease later…
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Inbrain Neuroelectronics’ neural platform for its…
The findings of new research identifying the mechanism behind a familial form of Parkinson’s — one caused by a…
An online artificial intelligence (AI)-powered test where users tap their fingers in front of a webcam may ultimately help rate…
Researchers have built a map of how neurons wire up in the zebrafish brain to propel forward and steer movement,…